Efficacy of Three Dimensional Transesophageal Echocardiography for Percutaneous Device Closure in Atrial Septal Defect
Recruiting
N/A
Interventional Study
Atrial Septal Defect
Successful Device Closure
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 – 80
- Sex
- Any
- Study type
- Interventional
- Purpose
- Diagnostic
- Participants needed
- 100 (estimated)
- Sponsor
- Asan Medical Center · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Background: Three-dimensional echocardiographic image for atrial septal defect (ASD) is useful for evaluation of defect size and shape. The investigators suggested optimal device size using three-dimensional transesophageal echocardiographic image and our formula in previous study.
Purpose: In this study, the investigators seek to predict the correct device size and confirm the accuracy of the fo…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Age ≥18 year-old
* Susceptible indication for atrial septal defect closure
* Potential candidate for device closure
Exclusion Criteria:
* Poor candidate for device closure: multiple ASDs, ect
* Other heart disease requiring open heart surgery
Contacts